New Outlook "Global Biosimilar Industrial Report" Market 2016, Demand, Analysis & 2020 Forecast
Description-
The
report titled “Global Combined
Hormonal Contraceptive
(CHC) Market: Trends and Opportunities (2014-2019)” provides an
in-depth analysis of the global CHC market with detailed analysis of
market sizing and growth, market share and economic impact of the
industry. The report also assesses key opportunities in the market
and outlines the factors that are and will be driving growth of the
industry. Growth of the overall CHC industry has also been forecasted
for the period 2014-19, taking into consideration the previous growth
patterns, the growth drivers and the current and future trends. An
insight into strategic issues affecting key brands on the market is
provided followed by an analysis of the leading companies in the
hormonal contraceptives market. The report also analyzes the key CHC
products in pipeline.Further, key players of the industry like Agile
Therapeutics; Bayer Healthcare; Teva Pharmaceuticals and Actavis PLC;
are analyzed in the report.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-combined-hormonal-contraceptives-chc-market-trends-and-opportunities-2014-19-report.html
Country
Coverage
- United states
- United Kingdom
- India
- China
- Japan
- Company Coverage
- Agile Therapeutics Inc.
- Actavis Plc.
- Bayer Healthcare
- Teva Pharmaceuticals
Executive
Summary
Combined
Hormonal Contraceptives (CHC) is widely being used as an effective
and reversible birth control method. Mainly used for preventing
pregnancies but sometimes also used for treating acne vulgaris,
endometriosis, polycystic ovarian syndrome and irregular menstrual
flow, CHC works by preventing ovulation i.e. release of egg from
ovaries. The hormones are provided in the combined pill, patch or
ring.
Most
popular Combined Hormonal Contraceptives products are Nuvaring and
Ortho Evra. CHC products are broadly used throughout the world by
women in the age-group of 15 to 49 years. With increasing health
consciousness and awareness, adoption of CHC products or birth
control methods is increasing in lesser privileged economic segments
too. The growth of CHC market is driven by urbanization and
increasing user awareness, rise in menstruating population globally
and initiatives taken by governments to encourage the use of
contraception. Major trends prevailing in the market are the
increasing number of mergers and acquisitions in this business space
and demand for reversible method of contraception with fewer side
effects.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment